| BACHEM N -B- | 379,50 / -0,39% |
| Datum/Vreme | 18.01. / 11:42 |
| Promena / Promena(%) | -1,50 / -0,39% |
| Tražnja | 379,00 / 41 |
| Ponuda | 380,50 / 106 |
| Cena na otvaranju | 381,00 |
| Prethodno zatvaranje | 381,00 |
| Najviša cena | 384,50 |
| Najniža | 379,00 |
| Obim [CHF] | 1.597.881,50 |
| Obim [Jedinice] | 4.191 |
| Dogovorena cena | 217 |
| ISIN | CH0012530207 |
| Simbol | BANB |
| Berza | SIX Swiss Exchange |
| Vrsta | Stock |
| Berza | Poslednja cena | Obim | |
|---|---|---|---|
| SIX Swiss Ex.. | 379,50 |  |
4.191 |
| London Inter.. | 379,00 | |
147 |
| Lang & Schwa.. | 351,50 | |
|
| Nasdaq Other.. | 418,0000 | 48 | |
| Cboe Europe .. | 129,20 | 126 | |
| Cboe Europe .. | 128,80 | 58 | |
| Turquoise | 128,80 | |
13 |
| Frankfurt | 115,0000 | 0 | |
| Berlin | 116,20 | 0 | |
| München | 114,80 | 0 | |
| Hamburg | 114,80 | 0 | |
| EUREX | Opcije | ||
Vesti
- Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome
14.05.2020 / 07:00 - GlobeNewswire - Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
04.05.2020 / 14:30 - GlobeNewswire - Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
28.04.2020 / 15:24 - GlobeNewswire - Vaccine Contract Manufacturing Market, 2030 - Market is Anticipated to Generate Revenues Worth USD 100 Billion by 2025
04.10.2019 / 10:05 - GlobeNewswire - Global Pharmaceutical Contract Manufacturing Market 2018-2025 - Patent Expiration Of Small Molecules Drugs & Advanced Technologies In API And FDF Manufacturing
26.03.2019 / 10:57 - GlobeNewswire
Realno vreme